Login Get Started
Browse
Shares
Healthcare
Biotechnology & Medical Research
Dimension Therapeutics Inc
Dimension Therapeutics Inc logo

DMTX - Dimension Therapeutics Inc Share News

$5.95 0.0  0.0%

Last Trade - 06/11/17

Sector
Healthcare
RiskRating
Size
Micro Cap
Style
Market Cap £n/a
Enterprise Value £n/a
Revenue £11.9m
Position in Universe th / 6715
Quality
Value
Momentum
StockRank™
StockReport™
Tools
Compare with... Run through checklist
Accounts
Balance sheet Income statement Cashflow statement Dividend summary
Charts News Discussions DMTX Dividends
All News
All News Reuters News Company Announcements
BRIEF-Dimension Therapeutics says on termination of merger with Ultragenyx co will be required to pay Ultragenyx a termination fee of $2.9 mln-SEC filing
3rd Oct '17 News
BRIEF-Ultragenyx to acquire Dimension Therapeutics
3rd Oct '17 News
BRIEF-Ultragenyx Pharmaceutical comments on Dimension Therapeutics' announcement
2nd Oct '17 News
BRIEF-Dimension board determines Ultragenyx's unsolicited proposal constitutes a "superior proposal"
2nd Oct '17 News
BRIEF-Dimension Therapeutics says co's board determined proposal from Ultragenyx Pharmaceutical could reasonably be expected to lead to "superior proposal"
19th Sep '17 News
BRIEF-DIMENSION CONFIRMS RECEIPT OF UNSOLICITED PROPOSAL FROM ULTRAGENYX
18th Sep '17 News
BRIEF-Ultragenyx proposes to acquire Dimension Therapeutics for $5.50 per share in cash
18th Sep '17 News
BRIEF-Dimension Therapeutics begins early-stage study testing gene therapy DTX301
31st Aug '17 News
BRIEF-Dimension Therapeutics to pay $2.9 mln to Regenxbio incase merger terminates
25th Aug '17 News
BRIEF-Regenxbio to acquire Dimension Therapeutics
25th Aug '17 News
BRIEF-Dimension Therapeutics Q2 loss per share $0.49
8th Aug '17 News
BRIEF-Dimension Therapeutics says Jean Franchi, CFO, has resigned
24th Jul '17 News
BRIEF-Dimension Therapeutics updates on strategic review
27th Jun '17 News
BRIEF-Dimension Therapeutics reports Q1 loss per share $0.54
10th May '17 News
BRIEF-Dimension announces interim topline results from ongoing phase 1/2 clinical program for DTX101
31st Jan '17 News
BRIEF-Dimension Therapeutics says FDA acceptance of investigational NDA for DTX301
13th Dec '16 News
BRIEF-Dimension therapeutics files for mixed shelf of up to $150 mln
10th Nov '16 News
BRIEF-Dimension Therapeutics reports Q3 loss per share of $0.58
10th Nov '16 News
BRIEF-Dimension Therapeutics announces orphan drug designation of DTX401
4th Oct '16 News
BRIEF-Dimension Therapeutics to submit investigational new drug application for DTX301
17th Mar '16 News
© Stockopedia 2021, Refinitiv, Share Data Services.
Youtube Instagram RSS
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.